Our year in numbers
3.97 million
New Zealanders who received funded treatments
16
Number of medicines with widened access
290,000
Estimated number of people benefitting from widened access to treatments.
20
Number of new medicines funded
74,000
Estimated number of people benefitting from new treatments funded
$1.186 billion
Budget spent on medicines, related products, and vaccines (Combined Pharmaceutical Budget)
$48.9 million
Money freed up from negotiations to reinvest in medicines, medical devices, and related products
10,000
Hospital medical devices added to the Pharmaceutical Schedule under national contracts
164,000
Hospital medical devices in the Pharmaceutical Schedule under national contracts
$30 million
Value of additional hospital medical devices secured under contract
These statistics are from the 2022/23 financial year (1 July 2022 to 30 June 2023) not the calendar year.